Rational use of myeloid growth factors in hemato-oncology.
Boogaerts
M A
MA
Dept. Hematology, University Hospital Leuven, Belgium.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D016298:Hematopoietic Cell Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors